Astellas Drug Reps Get Initial Class Cert. In OT Case
A New York federal judge on Thursday gave initial certification of a collective action alleging the U.S. affiliate of Japan-based Astellas Pharma Inc. misclassified current and former pharmaceutical representatives as exempt...To view the full article, register now.
Already a subscriber? Click here to view full article